JOFY KURIAKOSE: Open Payments
NPI 1912142977 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 37 payments from 9 companies in 2025. Trend: 2023 $500 · 2024 $702 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $375 |
| GENZYME CORPORATION | 5 | $233 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $123 |
| AstraZeneca Pharmaceuticals LP | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Amgen Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Circassia Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, AYVAKIT, NUCALA, FASENRA, Rhapsido, NIOX.
Industry payments across TX — which companies pay providers there.
